The modern machine learning and data engineering stack for immunomics-driven development of personalized immunotherapies and vaccines.
Helmholtz Munich, DE / PL
Joined August 2018
- Tweets63
- Following211
- Followers436
- Likes27
🧬 immunarch 0.10.3 and 🦋 immundata 0.0.5 – Release notes && news feed
b-t.cr/t/immunarch-will-sign…
We plan big updates for the immunarch. Write us if you want to help it get better. More details in this post:
b-t.cr/t/immunarch-will-sign…
Last year we learnt that CAR-T cells can survive for 10 years after infusion and prevent cancer relapse. This year opens with the news that murine T cells can survive multiple divisions exceeding mouse life span!
nature.com/articles/s41586-0…
ImmunoMind. retweeted
A new episode of #OnAIRR - the podcast of the AIRR Community is available. Vadim Nazarov of @immunomind discusses the use of AI for repertoire insights. Subscribe and listen in your favourite app or grab the episode here: onairr.airr-community.org
SkyNet is coming to your lab... but this is a good thing! Read more in the recent interview with our CEO Vadim a.k.a. @vadim_i_nazarov
This post was written by a fellow human.
Discover how digital laboratory tools provider eLabNext is teaming up with artificial intelligence (AI) software companies ImmunoMind and Modicus Prime to create new, integrated AI laboratory solutions – bit.ly/3MuPXz2 #artificialintelligence
If you have any questions, comments or problems – please open an issue in github.com/immunomind/immuna…. Feel free to leave a star – it is always appreciated
If you are interested more in the business side of the story and our cell therapy development efforts, check the LinkedIn page linkedin.com/feed/update/urn…
Thank you! ❤️
T cell research dominates the #AIRR field, while B cell research holds back, and many mysteries of B cells remain uncovered. In the next release of #immunarch we developed funs for BCR clonal lineage analysis. May the 4th be with you #bcells
Here is an analysis of B cell repertoires in two most common types of #autoimmune encephalitis
frontiersin.org/articles/10.…
In this paper scientists from MIT and BMS interrogated #BCR specificity in immune response against LPS. Their findings favor the idea of genetically encoded specificities for conserved microbial patterns. Check it out!
sciencedirect.com/science/ar…
#immunarch has become a popular library for #singlecell and #bulk BCR and TCR analysis. We plan to make a new release on GitHub and CRAN on May 10. Stay tuned for the updates!
In the meantime, you can read more about it in a recent review with an immunologist's perspective on AIRR analysis –
mdpi.com/2073-4409/10/12/358…
Results of the recent study inform a truly positive outlook on the CAR-T treatments. Modified cells have survived for a decade to provide tumor immunity
#CART #CellTherapy #singlecell
10xgenomics.com/blog/time-pl…
Today is a truly remarkable day for countless people working in biotech and healthcare, as well as their future clients and patients! Congratulations @Immunocore on making history!
Landmark day with the *first* FDA approval of a TCR therapeutic. Remember this day: it will be like 2017 was for CAR therapies. More will come, and quickly. Congrats @Immunocore @alexshoushtari and all of the other academic investigators.